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Abstract
Akt is a member of the AGC kinase family and consists of three isoforms. As one of the major regulators of the class I PI3
kinase pathway, it has a key role in the control of cell metabolism, growth, and survival. Although it has been extensively
studied in the nervous system, we have only a faint knowledge of the specific role of each isoform in differentiated neurons.
Here, we have used both cortical and hippocampal neuronal cultures to analyse their function. We characterized the
expression and function of Akt isoforms, and some of their substrates along different stages of neuronal development using
a specific shRNA approach to elucidate the involvement of each isoform in neuron viability, axon development, and cell
signalling. Our results suggest that three Akt isoforms show substantial compensation in many processes. However, the
disruption of Akt2 and Akt3 significantly reduced neuron viability and axon length. These changes correlated with a
tendency to increase in active caspase 3 and a decrease in the phosphorylation of some elements of the mTORC1 pathway.
Indeed, the decrease of Akt2 and more evident the inhibition of Akt3 reduced the expression and phosphorylation of S6. All
these data indicate that Akt2 and Akt3 specifically regulate some aspects of apoptosis and cell growth in cultured neurons
and may contribute to the understanding of mechanisms of neuron death and pathologies that show deregulated growth.
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Introduction
Neurons are perhaps one of the most challenging systems for
molecular and cellular biology. Their physiological function is only
possible because of their organization into morphological and
functional differentiated compartments resulting from a precise
coordination of extracellular and intracellular signalling pathways.
Akt (also known as Protein Kinase B– PKB) is a widely studied
protein that belongs to the AGC family of serine/threonine kinases
[1], showing a virtually ubiquitous distribution and playing a basic
role in nervous system. Initially described as the human homolog
of a viral oncogene [2], it is involved in many biological processes
and pathologies, such as metabolism regulation, cell growth,
survival, proliferation, cancer, and neurodegenerative disorders
[3]. There are three Akt isoforms encoded by three different genes
(Akt1/PKBa, Akt2/PKBb, and Akt3/PKBc). These paralogs are
closely related and share a high homology at protein level [4].
Extracellular signals induce Akt activation through class I
phosphoinositide 3-kinase (PI3K), for which it has been tradition-
ally considered as the main effector [3]. In this pathway, the
production of phosphatidylinositol (3,4,5)-triphosphate (PIP3) in
the plasma membrane leads to Akt activation by phosphorylation
through phosphoinositide-dependent kinase-1 (PDK1) and mam-
malian target of rapamycin complex 2 (mTORC2) in two amino
acids residues, threonine 308 and serine 473, respectively (amino
acid numbers corresponding to Akt1 isoform). [5]. Active Akt
exerts its function through the phosphorylation of a wide range of
substrates, including transcription factors as the FoxO family [6],
kinases such as Glycogen Synthase Kinase 3 (GSK3) [7], or
regulators of mTORC1 such as TSC2 [8] and PRAS40 [9].
Akt isoforms are differentially expressed and have been related
to distinct functions. Akt1 and Akt2 are widely expressed and
especially high levels of Akt2 are present in the heart, skeletal
muscle, adipose tissue, and testes. Akt3 expression is mainly
restricted to brain and testes, although it is also present in adipose
tissue, mammal glands, and lungs [4]. Furthermore, each isoform
is amplified in different cancer types [10]. Suppression of Akt
isoforms in knockout mice also reveals distinct physiological
functions for each isoform. Akt1 genetic ablation induces a
reduction of body and cell size [11,12], Akt2 knockouts show
diabetes mellitus-like syndrome [13,14], and Akt3 deletion causes
smaller brain size and corpus callosum disorganization [15,16].
Akt is involved in many physiological functions in the nervous
system, including the regulation of neuron survival [17,18,19],
estradiol and IGF-1 induced neuroprotection [20,21] and the
inhibition of GSK3, which plays a major role in physiological and
pathological conditions in brain.[17]. GSK3 presents two
ubiquitous isoforms coded by two different genes (GSK3a and
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GSK3b). Moreover, GSK3b has two splicing variants, GSK3b1
and GSK3b2, which are highly expressed in the nervous system
and are involved in the regulation of multiple functions [7],
including cell survival, metabolism and cell growth. Akt inhibits
GSK3a/b by phosphorylation of serine residues in the amino-
terminal region (serine 21 in a and serine 9 in b), which are
inserted into the kinase domain of GSK3, hindering the entry of
substrates [22]. Akt also plays an important role in development,
as it has been linked to neurogenesis [23] and to axon es-
tablishment and elongation through the regulation of GSK3
[24,25,26,27,28]. Altered Akt function has been associated to
pathologies such as Huntington’s disease [29,30], Alzheimer’s
disease [31], spinocerebellar ataxia type 1 [32], schizophrenia
[33], or autism [34]. In glial cells, Akt3 has an important role in
oligodendrocyte genesis [15,16] and a recent publication has
related Akt isoforms to astrocyte growth and glioma genesis in
PTEN and p53 null conditions [35].
Another substrate downstream the Akt pathway, mTORC1, is a
master regulator of metabolism, translational control, and cell
growth [36], and has also been involved in axon development and
growth [37,38,39] and in neurogenesis [40]. It has been proposed
that this process is regulated by the most studied substrates of
mTORC1, S6K1 [38] and 4EBP1 [37]. S6K1, a member of the
AGC kinase family, is involved in cell growth, insulin resistance
and regulation of protein translation through the ribosomal S6
protein [41], while 4EBP1 impairs eIF4E function and plays a role
in the repression of translation initiation [42]. Their role in axon
development has been proposed to be related to their function in
the regulation of the synthesis of proteins indispensable for axon
development [37,38].
We have only a faint knowledge of the specific function of each
Akt isoform in differented neurons. Here, we shed light on their
roles in neurons, using primary in vitro neuronal cultures widely
used to study the cell biology of the neuron. Primary neuron
culture allows for the analysis of isolated neurons under controlled
conditions without the interference of systemic perturbations [43].
They are also an established model of neuron development,
neuronal polarity, axonogenesis and dendritogenesis, or ionic
channel physiology [44] and have been largely used in studies of
neuron death [19].
We have characterized the evolution of Akt isoform expression
and function during the development of cortical and hippocampal
neurons in culture. For this purpose, we have used a short hairpain
RNA interference (shRNA) approach to analyse their involvement
in two of the main cellular processes regulated by Akt: cell viability
and axon growth. Finally, we describe how cellular signalling is
differentially regulated in neurons lacking one or another Akt
isoform by the action of specific interference shRNAs.. Our results
might help to understand the molecular basis of each Akt isoform
function in neuronal development and survival.
Results
Characterization of Akt isoforms and Akt activity in
neuronal cell culture development
In order to understand the role of each Akt isoform in neuronal
development, first we analysed the expression pattern of each
isoform during development in cultured embryonic cortical and
hippocampal mouse neurons. Thus, we cultured both types of
neurons for different days in vitro (DIV) and protein extracts were
obtained from 1, 2, 4, 6, 8 and 10 DIV neurons. The expression of
Akt 1, Akt2 and Akt3 along neuronal development at the days
indicated above was studied using specific antibodies against each
isoform (Figure 1). The data were normalised with respect to total
protein, GAPDH or b-actin, and represented as relative units. In
all cases the amount of 1 DIV was arbitrarily considered as 1
relative unit (Figure 1A).
In cortical neurons, Akt1 levels were relatively stable, with only
faint but significant changes at 4 DIV and 6 DIV. Akt3 levels were
also significantly reduced from 4 DIV to 8 DIV, but returned to 1
DIV levels at 10 DIV as observed for Akt1. Interestingly, Akt2
expression levels were very significantly reduced at 4 DIV and
Akt2 expression was only 22.268.66% (p,0.01) of that observed
at 1 DIV (Figure 1A). This reduction was maintained until 10
DIV (6 DIV: 25.861.31%, p,0.001; 8 DIV: 17.566.17%,
p,0.001; 10 DIV: 18.863.29%, p,0.001).
In contrast, the levels of the three Akt isoforms in hippocampal
neurons showed a tendency to reduction from 6 DIV, which was
statically significant (p,0.01) for Akt2 at 4 DIV and 6 DIV and for
Akt1 from 4 DIV on. Surprisingly, Akt3 levels were transiently
increased at 2 DIV and 4 DIV when compared with 1 DIV (2
DIV: 161.6614.4%, p,0.01; 4 DIV: 127.6611.9%, p,0.05)
(Figure 1A), even if Akt3 levels were also significantly reduced at
6 DIV. Next, we aimed at determining the cellular location of each
Akt isoform in neurons. However, no appropriate antibodies for
immunocytological analysis were found. Consequently, we tried to
obtain some indirect information using subcellular fractionation
methods with cortical primary cultures (Figure 1B). Antibodies
against GAPDH and the nuclear protein Lamin B1 were used as
internal controls for cytosolic and nuclear fractions, respectively.
Western blots results showed that all Akt isoforms were mostly
present in the cytosolic fraction. Interestingly, Akt3 showed a
higher nuclear to cytosol ratio. In contrast, the three isoforms were
barely detected in the membrane fraction (Figure 1B).
Once we had obtained the temporal expression pattern of each
Akt isoform and their subcellular locations, we studied the activity
of Akt during neuronal development. The activity of Akt may be
inferred by two different approaches. First, the phosphorylation
level of Akt pT308 and Akt pS473 has been correlated with a high
activity of Akt [5]. Second, the phosphorylation level of its
substrate GSK3, on serine 21/9, is commonly used as a reporter of
Akt kinase activity [3,7]. Thus, we analysed our neuron cultures
with phospho-specific antibodies against Akt pT308 and Akt S473
(Figure 2).
The analysis of cortical neurons protein extracts showed an
important increase with respect to 1 DIV of total Akt pT308 levels
normalized to total Akt levels which was statistically significant
from 6 DIV to 10 DIV (6 DIV: 565.86117.5%, p,0.001; 8 DIV:
726.46419.1%, p,0.05; 10 DIV: 624,86158.2%, p,0.001).
However, no changes were observed in total Akt S473
phosphorylation. The analysis of total Akt showed a small non-
significant reduction from 2 DIV (Figure 2). Interestingly, the
data from hippocampal neurons cultures (Figure 2) showed that
Akt phosphorylation at T308 and S473, increased significantly
from 6 or 8 DIV with respect to 1 DIV. Akt phosphorylation levels
at T308 were 195.9614.4% at 6 DIV, p,0.001; 415.56180.9%
at 8 DIV, p,0.01; 442.56139.1% at 10 DIV, p,0.001; whereas
the ones for Akt pS473 were 316688.6% at 8 DIV, p,0.05, and
359.267.52% at 10 DIV, p,0.001. Interestingly, in contrast to
what was observed in cortical neurons, total Akt decreased
significantly from 6 DIV on, its levels being 47.667.17% at 6
DIV, p,0.05; 28.366.64 at 8 DIV, p,0.05; 28613.6% at 10
DIV, p,0.05, with respect to 100% at 1 DIV (Figure 2).
Additionally, we quantified the Akt-regulated phosphorylation of
GSK3 as a measure of Akt activity. Our data showed a slight rise
of GSK3 phosphorylation in cortical neurons at 2 DIV and a
tendency to reduction in hippocampal cultures from 4 DIV on
(Figure 2). Total GSK3 increased significantly at 8 DIV and 10
Specific Role of Akt3 in Neurons
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e32715
DIV respect to 1 DIV in both cortical (8 DIV: 153.1617.7%,
p,0.05; 10 DIV: 197.669.45%, p,0.001), and hippocampal
cultures (8 DIV: 203631.1%, p,0.05; 10 DIV: 136.660.621%,
p,0.001).
Next, we analysed the kinase responsible for Akt phosphoryla-
tions at T308 and S473. It is generally accepted that PDK1 and
mTORC2 would be the responsible kinases for these phosphor-
ylations [3]. Thus, considering our previous data, we analysed the
amount and evolution of PDK1 and the mTORC2 component
protein, mSin1, in our neuronal cell cultures.
Our data indicated that PDK1 did not show relevant
differences in expression along the time in cortical or hippocam-
Figure 1. Akt isoforms levels change during neuron development. A. Ex vivo evolution of the isoforms of Akt in cortical (left) and
hippocampal (right) neuron cultures at 1, 2, 4, 6, 8 and 10 days in vitro (DIV). Cell extracts were obtained as described in Methods, and Western blots
analysed with specific antibodies against each isoform. b-actin was used as loading control for cortical neurons and GAPDH for hippocampal neurons.
Western blots were quantified and normalised with respect to the control protein as indicated. The data from 1 DIV was always considered as 1
relative unit and the values are represented in logarithmic scale. The graphs represent three independent experiments (each point represents mean
6 SEM). Samples were compared to 1 DIV using Student’s t test; *: p,0.05; **: p,0.01; ***: p,0.001. In cortical neurons Akt2 and Akt3 levels were
reduced from 4 DIV on and Akt1 changes slightly at 4 DIV–6 DIV. In hippocampal neurons, Akt1 levels decreased from 6 DIV on, Akt2 showed a
tendency to reduction from 4 DIV on (which is statistically significant at 4 DIV and 6 DIV) an Akt3 is slightly increased at 2–4 DIV. B. Subcellular
distribution of Akt isoforms. Total extract from cortical neurons was fractionated as indicated in Methods. For each sample (membrane, citosol and
nucleus) the presence of Akt isoforms was determined by Western blot. Lamin B1 was used as marker and loading control for the nuclear fraction and
GAPDH for the cytosolic fraction. Note that Akt3 showed a relatively higher nuclear proportion than the other isoforms.
doi:10.1371/journal.pone.0032715.g001
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pal neurons cultures, and no evident correlation was observed
between the degree of Akt phosphorylation and these protein
levels. (Figure S1). Regarding mSin1, our data indicated the
presence of two isoforms; of these, only the high molecular weight
isoform is part of mTORC2 [45]. When we quantified the high-
molecular weigh component, we detected a low increase in
Figure 2. Evolution of the Akt-GSK3 pathway during neuron development. The presence of Akt and GSK3 and their phosphorylation levels
were analysed in cortical (left) and hippocampal (right) neuron cultures at 1, 2, 4, 6, 8 and 10 day in vitro (DIV). The cell extract was analysed by
Western blot using antibodies against pan-Akt, Akt pT308, Akt pS473, GSK3a/b and GSK3a/b pS21/9. b-actin was used as load control for cortical
neurons and GAPDH for hippocampal neurons. Western blots were quantified and normalised with respect the control protein as indicated in
Figure 1, and the values are represented in logarithmic scale. The graphs represent three independent experiments (each point represents mean 6
SEM). Samples were compared to 1 DIV using Student’s t test; *: p,0.05; **: p,0.01; ***: p,0.001. Note that Akt activating phosphorylations were
increased during both cortical and hippocampal neuron development from 6 DIV on but no correlation was observed with the phosphorylation
status of its substrate GSK3a/b. Total levels of GSK3a/b increased during development in both types of cultures.
doi:10.1371/journal.pone.0032715.g002
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hippocampal neurons and no differences when we analysed
cortical ones (Figure S1).
Characterization of Akt-mTORC1 signalling in neuron
cultures
Besides being a substrate of Akt, mTORC1 plays an essential
role in neuron development [46]. For this reason the evolution of
the main elements known of this pathway were also studied
(Figure 3 and Figure S2).
The mTORC1 downstream proteins S6K1, its substrate S6,
and 4BEP1 were analysed (Figure 3). In cortical neurons, there
was a statistically significant reduction in S6K1 phosphorylation at
T389, an activating phosphorylation regulated through
mTORC1. S6K1 pT389 levels were 54.6612.4% at 6 DIV,
p,0.05, and 64.7612.7% at 8 DIV, p,0.05 compared to a 100%
at 1 DIV. Total S6K1 levels showed also faintly but statistically
significant changes at 4 DIV. Phosphorylation of its substrate S6
on S235/236 was increased at 4 DIV and after this time tended to
a transient decrease. Interestingly, total S6 increased from 6 DIV,
being 1669.56114.12% at 10 DIV compared to 1 DIV.
In hippocampal cultures, a decrease in S6K1 phosphorylation
was also observed after 8 days of culture, which became
statistically significant at 10 DIV, four days later than in cortical
neurons. The total amount of both total S6K1 and S6 remained
practically unaltered along the culture development, whereas the
phosphorylation level of S6 decreased when compared with 1 DIV
(36.8+12.3% at 8 DIV, p,0.05; 27.1+12.5% at 10 DIV, p,0.05;
Figure 3). In this case, changes in S6K1 phosphorylation
correlated with a reduction in phosphorylation of its substrate
S6. Next, we analysed the phosphorylation degree of other
mTORC1 pathway substrate, 4EBP1, which is phosphorylated on
T37/46. Phosphorylation levels remained almost stable along the
development of both cortical and hippocampal neurons.
In view of the changes observed in S6K1 and S6 phosphory-
lations, we tried to determine whether mTORC1 function
activation by Akt was mediated through Akt phosphorylation of
the mTORC1 inhibitors, TSC2 and PRAS40 [8,9]. Our data
shows that Akt-induced phosphorylation of these substrates
displayed a faint but significant decrease from 2 DIV during the
development of cortical neurons (Figures S2, left panel), that
may correlate with the results observed for S6K1 pT389 and S6
pS235/236 phosphorylations, but not for 4EBP1 pT37/46. In
addition, PRAS40 phosphorylation was also slightly reduced in
hippocampal neurons, and it is important to note that total levels
of TSC2 showed a marked decrease in the last days when
compared with 1 DIV (20.5+10.1% at 8 DIV, p,0.05;:
11.4+1.72% at 10 DIV, p,0.001) (Figures S2, right panel).
ShRNA-induced disruption of Akt2 and Akt3 reduces
neuron viability
After the characterization of Akt and some of its upstream and
downstream regulatory elements in cultured hippocampal and
cortical neurons, we then examined the functions of each Akt
isoform. Using interference RNA technology, we studied their
roles in cell survival and axon growth, two of the main neuronal
events in which Akt has been involved. Akt function has been
proposed to be crucial for the maintenance of neuron viability and
for neuroprotection [17,18,19]. Thus, we decided to study the
involvement of its isoforms in cell survival.
Using specific shRNAs, we analysed neuronal cell viability after
removal of each isoform on cortical neurons (Figure 4). Cortical
neurons were infected with lentiviral vectors at 1 DIV, once the
neurons have adhered to the plate and after a day of adaption to
culture medium, and cell viability was determined three days after
infection using a propidium iodide-calcein assay (Figure 4A–B).
At this time, the efficiency of shRNA interference was established
by Western blot. Results showed a reduction of over 50% for every
isoform in all cases (Figure 4B). Our data indicates that only the
disruption of Akt2 and Akt3 led to a slight but statistically
significant reduction of neuron survival percentage under the
standard culture conditions when compared with control scram-
bled shRNA infected neurons (79.0461.74% in shControl:;
60.6066.58 in shAkt2, p,0.05, 70.3764.76% in shAkt3,,
p,0.05, n = 3) (Figure 4B–C). This reduction on cell viability
correlated with a tendency of an increase in active caspase-3 (the
most commonly used apoptotic marker [47]), in either Akt2 and
Akt3 (Figure 4C).
As a positive control, the apoptotic effect of Akt inactivation was
confirmed using the specific Akt inhibitor VIII, which binds to Akt
and impedes its phosphorylation by PDK1 and mTORC2 [48].
The propidium iodide-calcein assay showed that inhibition of
Akt induced a marked decrease in neuron viability and only
55,4610,1% of neurons were viable (Figure 4D). The inactiva-
tion of Akt was confirmed by the decreased phosphorylation of
both T308 and S473 Akt residues (Figure 4D–E). As expected,
this inhibition induced a high increase of cleaved caspase 3
(Figure 4E). These results suggest that Akt2 and Akt3 play
specific and non-redundant roles in neuron survival by regulating
apoptotic pathways.
Role of Akt isoforms in axon development
Axon growth is one the first and more characteristic events of
neuron development and it is regulated by a complex network of
signaling pathways that involves extracellular and intracellular
molecules. It is generally accepted that the PI3K pathway plays a
critical role in promoting both axon differentiation and growth.
Consequently, we asked if Akt isoforms are differentially involved
in this cellular process. For this purpose, we used hippocampal
neurons as the most extended model to study axonal polarity [44].
In standard hippocampal cultures, an axon is established between
1 DIV and 3 DIV [49]. Therefore, the isoform-specific shRNAs
were nucleofected into hippocampal neurons before plating, to
obtain a highly efficient delivery of shRNA-containing plasmids.
Next, neurons were grown under the standard conditions for 3
days, fixed, and axon growth was checked by immunocytochem-
istry with the specific axonal marker Tau-1 [50] (Figure 5A). The
presence of axons and their length were quantified in neurons
lacking each Akt isoform.
Despite the effects described for whole Akt activity inhibition
[24,25,26,27,28], depletion of each Akt isoform did not exert
statistically significant changes in neuron polarity and more
than 80% of neurons extend one axon (Figure 5B). However,
interference of Akt2, and to a greater extent that of Akt3, reduced
axon length with respect to control neurons. Axonal length of
shAkt2 nucleofected neurons was only 85.764.26% of that shown
by control neurons (p,0.01), and 73.864.73% in the case of
shAkt3 (p,0.001) (Figure 5C).
Akt isoforms regulation of cell signaling
Our results show that specific Akt isoforms disruption have
differential effect on neuron viability and axon growth, thus we
decided to analyse the effect of Akt isoforms suppression on
downstream elements. Considering that Akt isoform levels
changed along the culture development (Figure 1), neuronal
cultures were infected at two significant times, 1 DIV and 6 DIV.
After lentiviral transduction, neurons were harvested 3 days later
to study the potential variability on signaling. Following the same
Specific Role of Akt3 in Neurons
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e32715
previous scheme used in our study along neuronal development,
Akt activating phosphorylation and Akt substrates were analysed.
The efficiency of interference was determined by Western blot as
an internal control after each experimental condition, using the
specific antibody against each Akt isoform (Figure 6A).
The interference of Akt1 and Akt3 did not modify the level of
Akt pT308 significantly, even though Akt1 represents half of the
Figure 3. Evolution of mTORC1 substrates during neuron cultures. Elements of this pathway were analysed in cortical (left) and hippocampal
(right) neuron cultures at 1, 2, 4, 6, 8 and 10 day in vitro (DIV). Cell extracts were evaluated using antibodies against S6K1, S6K1 pT389, S6, S6 pS235/
236, 4EBP1 and 4EBP1 pT37/46. b-actin was used as load control for cortical neurons and GAPDH for hippocampal neurons. Western blots were
quantified and normalised with respect the control protein as indicated in Figure 1, and the values are represented in logarithmic scale. The graphs
represent three independent experiments (each point represents mean6 SEM). Samples were compared to DIV1 using Student’s t test; *: p,0.05; **:
p,0.01; ***: p,0.001. Although the mTORC1 phosphorylation on 4EBP1 remained stable in both kind of cultures, in cortical neurons S6K1 pT389
decreased on 6–8 DIV, and its substrate S6 pS235/236 showed a tendency to reduction beginning on 6 DIV. In hippocampal cultures, S6K1 pT389 was
reduced on 10 DIV and its substrate S6 pS235/236 decreased on 8–10 DIV.
doi:10.1371/journal.pone.0032715.g003
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total Akt expression (Figure 6B). In contrast, Akt2 disruption was
related to a reduction of total Akt pT308 both in 1 DIV infection
(62.29%68.80 respect to the control; p,0.01, n = 3) and 6 DIV
infection conditions (52.41%+7.20 respect to the control; p,0.01,
n = 3), although no significant changes were observed in total Akt
pS473 (Figure 6B). The use of Pan-Akt antibody did result in a
western-blot double band. Akt1 interference is linked to a
reduction in the upper band and Akt3 disruption is linked to a
decrease in the lower one (Figure 6B). Despite the changes in Akt
isoforms expression and Akt phosphorylation at T308, when we
analysed GSK3, one of the main substrates of Akt, we did not
observe any significant changes in either GSK3 phosphorylation
or total expression levels (Figure 6B).
Then, we analysed the mTORC1 pathway, the main effector of
Akt in cell growth and translation control (Figure 3 and
Figure 7). First, we analysed the mTORC1 regulators, TCS2
and PRAS40. Our data showed that after Akt-isoform interference
no statistical change was obtained in TSC2 and PRAS40 (Figure
S3). Next, we analysed the phosphorylation state of S6K1 on
T389, but interestingly it was almost not modified after infection
Figure 4. Akt isoforms differentially regulate neuron survival. Cortical neurons were infected with lentiviral vectors containing shRNAs at 1
DIV for six hours (A–D). As a control of the effect of total Akt inhibition, neurons were treated with the Akt inhibitor VIII 5 mM from 1 DIV (D_E). The
viability was assayed using a propidium iodide-calcein assay performed on 4 DIV. A. Representative photographs for shRNA containing lentiviral
infection. B. Percentage of viable cells (Calcein-positive). Each sample was compared to control (ShC) using Student’s t test (bars represent mean 6
standard deviation; *: p,0.05). Note that the disruption of Akt2 and Akt3 caused a significant reduction on neuron viability. C. ShRNA interference
was confirmed at 4 DIV by inhibition of protein expression using specific antibodies. Apoptosis was evaluated at 4 DIV by the presence of active
caspase 3 associated to shRNA-induced Akt2 and Akt3 reduction (Lower panel). D. To identify the maximal effect due to Akt inhibition, in parallel we
treated neurons with for Akt inhibitor VIII (5 m m). Representative photographs for Akt inhibitor VIII treatments. The graphs correspond to the
quantitative determination of viable neurons, either after inhibitor VIII or DMSO treatments (represented as percentage of calcein-positive cell). In
each independent experiment (n = 3), data from Akt-VIII was compared to control (DMSO) using Student’s t test (bars represent mean 6 standard
deviation; **: p,0.01). E. Inhibition of Akt was confirmed at 4 DIV by reduction of Akt activating phosphorylation levels (Akt pT308 and Akt pS473).
And the maximal level of apoptosis was evaluated at 4 DIV (right panel), by the presence of active caspase 3 associated to Akt-VIII inhibitor (Akt-I).
doi:10.1371/journal.pone.0032715.g004
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with shAkts, in either 1 DIV or 6 DIV neurons (Figure 7).
However, the analysis of S6 showed that S6 phosphorylation was
reduced by shAkt2 when infecting at 1 DIV (60.60627.04%
respect to the control; p,0.05, n = 3) and 6 DIV (48.52622.96%;
p,0.05, n = 3), and more severely reduced by shAkt3 when
infecting at 1 DIV (41.99616.67%; p,0.05, n = 3). In contrast, no
Figure 5. Akt isoforms differentially regulate axon growth but do not affect axon establishment. Hippocampal neurons were
nucleofected with the indicated shRNAs and a GFP-expressing plasmid, and analysed later on DIV 3. A. Neurons were fixed and anti-Tau-1 antibody
was used as an axonal marker. The photographs correspond to a representative field for each experimental condition in which the Tau-1 positive
and/or GFP-positive neurons were observed. Scale bar: 25 mm. B. Data indicated that Akt isoforms disruption did not induce a statistically significant
change in neuron polarity (each condition was compared to control using Student’s t test; bars represent mean 6 standard deviation). C. However,
when the axonal length were determined (form those GFP-positive and Tau-1-positve neurons), the disruption of both Akt2 and Akt3 caused a
reduction of axon length (samples were compared to control using Mann-Withney test as they did not show a normal distribution; bars represent
mean 6 SEM; **: p,0.01, ***: p,0.001).
doi:10.1371/journal.pone.0032715.g005
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change was detected after shAkt1 infection. When we analysed the
other mTORC1 direct substrate, 4EBP1, no statistical change was
observed in its T37/46 phosphorylation (Figure 7 A).
Finally, it has been proposed that Akt isoforms could regulate
upstream events in the MAPK pathway in different cell types
[55,56]. Therefore, we asked if Akt isoforms could regulate the
MAPK pathways. We checked the final activating phosphoryla-
tion of the three main MAPKs (ERK, JNK and p38), commonly
used as a reporter of the activation of these pathways [51]. No
statistically significant variation was found in either of them in
standard neuron culture conditions (Figure S4).
Discussion
Akt isoforms along neuronal development
We have analysed the roles of Akt isoforms during development
of cortical and hippocampal neuron cultures. We first observed
variations in specific Akt isoform expression levels and in some of
their substrates during development. Our results show that the
ratio and the timing of expression of each isoform is different,
which is very evident for the reduction of Akt2 expression levels in
cortical neurons. Even though the specific commercially available
antibodies did not permit the immunocytochemistry analysis of the
neuronal location of each isoform, the subcellular distribution
obtained after cell fractionation allowed us to propose that Akt3
presents a higher nucleus to cytosol ratio.
In general, the decrease in Akt isoforms contrasts with the
increase in Akt activity, which was inferred from the levels of the
activating phosphorylations, in both types of neurons. However,
when we analysed some direct substrates such as GSK3 or S6K,
GSK3 serine phosphorylation showed only a faint increase
whereas S6K1 phosphorylation on threonine 389 appeared to
be unmodified in cortical neurons, and showed a minor reduction
in hippocampal neurons. Importantly, when we analysed the total
S6 protein levels an important increase was detected in cortical
neurons, but the S6 phosphorylation decreased in both neuronal
models with respect to the S6 total protein. Thus, the increase in
Akt phosphorylation after Akt-interference may be a compensa-
tory mechanism, trying to maintain TORC1 activity and GSK3-
inhibition.
In general, the decrease in Akt isoforms contrasts with the
increase of activating phosphorylations of total Akt, in both types
of neurons. However, when we analysed some substrates of this
pathway, little correlation was found between these phosphoryla-
Figure 6. Regulation of Akt-GSK3 pathway by Akt isoforms. Cortical neurons were infected with lentiviral vectors containing shRNA at two
times (1 DIV and 6 DIV) for six hours. 72 h after the infection cell extracts were obtained (at 4 DIV and 9 DIV respectively). A. As an internal control,
shRNA induced interference was confirmed by protein expression using specific antibodies against each Akt isoform. B. The effect of Akt interference
was analysed using antibodies against Akt and GSK3: pan-Akt, Akt pT308, Akt pS473, GSK3a/b and GSK3a/b pS21/9. b-actin was used as load control.
Akt1 and Akt3 may be identified as two different bands marked by the pan-Akt antibody. Although Akt2 disruption caused a slight decrease in Akt
pT308, no other significant changes are observed.
doi:10.1371/journal.pone.0032715.g006
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tions and downstream substrates, such as GSK3 or the mTORC1
pathway. GSK3 serine phosphorylation, which is commonly used
as a reporter of Akt activity, showed only a faint increase.
Nevertheless, the total GSK3 was also increased, so the higher
activation of Akt could be compensating the greater amounts of
this substrate; thus, GSK3 inhibition could be maintained at
suitable levels for correct cellular function.
Conversely, S6K1 phosphorylation on threonine 389, which is
mediated by mTORC1 appeared to be unmodified in cortical
neurons, and showed a minor reduction in hippocampal neurons.
Importantly, when we analysed the total S6 protein levels a
significant increase was detected in cortical neurons, but the S6
phosphorylation decreased in both neuronal models with respect to
the S6 total protein. S6 phosphorylation mediated by the S6Ks has
been traditionally linked to cell growth [41,52], so the reduction
observed could reflect a decrease in the growth rate during
development. However, the phosphorylation of 4EBP1, also directly
regulated by mTORC1, showed no significant changes during
neuron culture development. As it will be discussed later, S6K1
activity is also regulated by other proteins besides mTORC1 [53],
so the difference observed between S6K1.S6 and 4EBP1 might be
due to a regulation of S6K1 independent of mTORC1.
Functional redundancy and divergence of Akt isoforms
The contrast between Akt isoform expression and GSK3 or
S6K1 activities observed during neuronal development points to
either a functional redundancy or a functional divergence of Akt
isoforms that may mask the specific function of each isoform. Our
Figure 7. Regulation of mTORC1 substrates by Akt isoforms. Cortical neurons were infected with lentiviral vectors containing shRNA at two
times (1 DIV and 6 DIV) for six hours; proteins were extracted 72 h after the infection (at 4 DIV and 9 DIV respectively). The cell extract was examined
using antibodies against the canonical substrates of mTORC1 pathway: p70 S6K1, p70 S6K1 pT389, S6, S6 pS235/236, 4EBP1 and 4EBP1 pT37/46. b-
actin was used as load control. The interference was confirmed by protein expression using specific antibodies as previously indicated (see
Figure 6A). A. Note that Akt2 and Akt3 regulated S6 phosphorylation but no statistical change was observed in the direct mTORC1 substrates S6K1
and 4EBP1. B. The relative level S6 pS235/236 with respect to the total S6 was determined, at 4 DIV by Western blot (each condition was compared to
control using Student’s t test; bars represent mean 6 standard deviation).
doi:10.1371/journal.pone.0032715.g007
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results show that suppression of one specific Akt isoform results in
faint changes in most of the Akt downstream substrates during
neuronal development. However, when we analysed the effect of
each one of the Akt shRNAs on neuron survival and axon
development, only Akt2 and Akt3 disruption induced a little but
significant reduction of neuronal survival and axonal length. Thus,
as a perfect example of paralogs, Akt isoforms show high func-
tional redundancy and some evidence of function divergence. In
fact, Akt1 suppression may be compensated by Akt2 and/or Akt3
expression, but neither Akt2 nor Akt3 loss of function is completely
compensated by Akt1 expression.
Although we have focused on the effect of Akt isoforms in
differentiated neurons, our results are consistent with previous
studies regarding the global effect of these proteins. Knock-out
mice for each isoform are viable and show only minor alterations
[4]. However, total Akt is believed to play a central role in
the nervous system, as many studies based on pharmacological
inhibition or gain of function Akt mutants have been proposed to
be crucial for neuron survival and growth [17,18,19] or axon
establishment [24,25,26,27,28] among many other processes.
Altogether, both our results and previous data suggest that Akt
isoforms show substantial compensation in many processes.
However, single isoform knockout experiments have also
reported specific functions for these proteins. For example, Akt1
plays a role in placental development, growth and adipose tissue,
Akt2 is related to growth and insulin response and Akt3 is linked to
brain growth and oligodendrocyte genesis [4]. They also show a
differential tissue distribution, which may be related to differential
function [11] and are amplified in different cancer types [10].
Differential regulation of downstream substrates under different
conditions has also been reported for distinct cell types [54,55].
Consistent with these observations, we have found that the
isoforms of Akt differentially regulate some aspects of neuronal
function.
Most of the work describing specific functions of Akt isoforms
indicate that Akt1 and Akt2 differentially regulate many cellular
processes, sometimes even playing opposites roles [54]. These
isoforms have been extensively studied in regulation of metabolism
[10,56] and cancer [10,54]. So far, Akt3 has not been as deeply
characterized as its two paralogs. Interestingly, our results show
that Akt3 disruption exerts the most prominent effect on dif-
ferentiated neurons rather than Akt1 or Akt2. This effect could be
specific for the cell type we have studied, as Akt3 is restrictively
distributed, with a high grade of expression in the nervous system
[11], while Akt1 and Akt2 are almost ubiquitously expressed in all
tissues.. In summary, our results suggest that Akt3, and Akt2 in a
minor manner, might play a role in some aspects of neuron
biology that could be specific for this cell type.
Akt isoforms differentially regulate neuron viability
We analysed cell survival processes in which Akt has been
involved. Different elements under the control of PI3K have been
particularly associated with the maintenance of neuron viability
and in neuroprotective mechanisms [17,18,19]. In fact, it is
generally accepted that class I PI3Ks play a central role in cell
survival in many if not all cell types [57]. However, our data
indicated that only the disruption of Akt2 and Akt3 induces a small
but significant reduction of cell viability in cortical neurons that
correlates with the activation of caspase 3 [58]. These results
suggest that some aspects of Akt regulation of apoptotic pathways
are exclusive to Akt2 or Akt3 despite some apparent redundancy
among the isoforms.
Many works show that Akt is related to the regulation of
apoptosis by a complex cell signaling network; the elements of this
network may be different in distinct cellular systems and show
a precise subcellular distribution, being located in the cytosol,
nucleus or mitochondria (reviewed in [59]). GSK3 is one of the
main substrates of Akt and its inhibition has been proposed as an
essential mechanism for the maintenance viability of neuronal cells
[17]. However, our data showed no change in GSK3 phosphor-
ylation associated with decreased cell viability induced by Akt2
and Akt3 disruption. Thus, we conclude that the ablation of a
single isoform is not directly linked to the classical inhibition of
GSK3 pro-apoptotic activity.
Although we have not yet determined the downstream mo-
lecular mechanism, our results suggest that, at least in some
neuronal types, one of these isoforms would control neuronal
survival. Interestingly, the Akt3 knockout experiments show results
similar to ours, as hippocampal cultured neurons from Akt32/2
mice show reduced cell viability in response to injury but no
reduction was observed in tissue for GSK3 phosphorylation [16].
Akt3 has been localized in the mitochondria in HEK293 cells [60]
and our data indicate that it presents a higher nuclear expression
than any other Akt isoform. As mentioned above, some substrates
of Akt involved in the regulation of cell survival are located in
these two subcellular structures [59]. Thus, Akt3 could be involved
in fine regulation of apoptotic mechanisms in these subcellular
compartments. Besides the classical action of GSK3 in neurons, in
other cell types many proteins have been proposed to be associated
with the control of the apoptosis /survival pathway mediated by
Akt [59], such as hexokinases (regulators of the cytochrome C in
mitochondria) [61], Bad [62,63] or Bax [64], pro-apoptotic and
anti-apoptotic transcription factors, such as FoxO [65,66], CREB
[67] or Mdm2.p53 [68]. Further work will help us to elucidate
the specific function of Akt isoforms in this complex process.
Role of Akt isoforms in axon growth
It has been proposed that Akt plays a critical role in axon
development [24,25,26,27,28] partially based on the observation
that PI3K [69], as well as IGFR-I, have been reported as master
regulators of axonal polarity [70]. In addition Akt has been
proposed to be a pivotal element in this process because PI3K
downstream elements such as GSK3 play an essential role in
axonal elongation [24,25,26,27,28,71], and lack of GSK3a or
GSK3b impede axonal elongation [71]. Neuronal polarization is
the basis of neuronal morphological differentiation and it is crucial
for correct neuron physiology [44,72]. Thus, we decided to
evaluate the specific function of each isoform in the most extended
model for these studies in central nervous system cells: cultured
hippocampal neurons. We focused on two parameters that reflect
different cell processes: axon establishment, which is a marker of
cell polarization and asymmetric distribution of cell components,
and axonal elongation. In hippocampal cultures, embryonic
neurons start to project similar neurites a few hours after plating,
one of which grows at a faster rate than the others and becomes a
differentiated axon at 2–3 DIV by a molecular mechanism not
completely understood [49]. However, our results indicate that
Akt isoform depletion does not affect axonal polarization, even
though the final length of the axon is statistically reduced. This
lack of effect may reflect the lack of GSK3 phosphorylation
changes. Also, the data suggest that compensatory mechanisms
can resolve the possible defects produced by suppression of single
Akt isoforms. In addition, GSK3 has proven to be inhibited by
other AGC kinases under certain conditions (PKC, S6K, SGK,
etc.) [7], and thus, the establishment of neuronal polarity and axon
differentiation may be driven even by other proteins. In fact, some
bbbevidence suggests that atypical PKC could be the former
GSK3 regulator involved in neuron polarity rather than Akt [73].
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The reduction of axonal length opens the possibility that
others Akt substrates may be implicated in this process. Indeed,
mTORC1 has been proposed as another essential factor in axon
formation [37,38,74,75]. However, to our knowledge no work has
directly established a link between Akt regulation of mTORC1
and axon formation, so Akt may not participate in mTORC1
control of polarization. Two elements of this pathway have been
proposed to be critical: 4EBP1 [37] and S6K1 [38]. In cortical
neurons, the first one is not altered by single Akt isoform dis-
ruption, and mTORC1-regulated S6K1 phosphorylation shows
only minor changes, which correspond with the unaltered neuron
polarity we observed for hippocampal cultures. These results
suggest that both Akt2 and Akt3 could be related to mTORC1-
regulated cell growth, which has been related to S6 phosphory-
lation [41], but no isoform seems to be indispensable for
mTORC1 regulated cap-dependent translation initiation, which
is mediated through 4EBP1 [76].
Differential regulation of mTORC1 substrates implicated
in cell growth by Akt isoforms
ShRNAs against Akt2 and Akt3 have a significant effect on
hippocampal axon length, and there is a correlation between this
effect and a reduction in S6 phosphorylation in cortical neurons at
the times of maximal axon growth which were considerably clear
when Akt3 was depleted. Axon development is the main event
in general neuron growth [49] and the S6K.S6 pathway is
considered one of the master regulators of cell growth [41,52].
Thus, Akt2 and Akt3 isoforms may be regulating general neuron
growth through the S6K.S6 pathway at this stage and the
observed reduction in axon length may reflect this global process
(cell growth) instead of an effect specific for axon development.
Knock-in experiments indicate that S6 phosphorylation on
S235/236 is strongly associated with cell growth [52]. However,
we did not observe a statistically significant reduction of S6K1
pT389, with poor correlation with S6 phosphorylation. Although
S6 phosphorylation is commonly used as the activation reporter
for this pathway, the S6Ks are a node of convergence for distinct
cell signaling pathways [53], including the mTORC1, PDK1 [77],
and some Ser-Pro directed kinases that may be identified as CDKs
[78,79]. Also, there are two S6 kinase paralogs, which are believed
to be similarly regulated: S6K1 and S6K2 [80]. S6K2 is
ubiquitously expressed and seems to have a crucial role in this
pathway [80]. Indeed, some data suggest that S6K2 may be the
main kinase responsible for S6 phosphorylation, rather than S6K1
[81,82]. The PI3K pathway has been shown to play a central role
in its regulation [83]. S6K1 and S6K2 show different subcellular
distribution, as S6K1 is believed to be primary cytosolic and S6K2
is located in the nucleus [80], suggesting that both are implicated
in different cellular processes. Unfortunately, we lack of the tools
necessary to study S6K2 yet, as it has received less attention than
S6K1 during the last years.
The regulation of S6Ks by Akt isoforms is not clear. Our results
indicate that the direct substrates of mTORC1, 4EBP1 and S6K1
are not altered by Akt2 and Akt3 disruption, but the S6K activity
towards S6 is reduced. We have observed a similar ‘‘uncouple
effect’’ between mTORC1 action on its direct substrates and S6
phosphorylation during cortical and hippocampal culture devel-
opment. There are different explanations for this observation. Akt
isoforms might play a role in the regulation of S6K affinity towards
its S6 substrate (i.e., through modification of scaffolding proteins
or cellular distribution), could also regulate S6K activity in an
mTORC1 independent manner, or even may act upstream of a
mTORC1 pool specifically related to S6 phosphorylation, possibly
by regulation of S6K2 activity. The fact that both Akt3 and S6K2
show nuclear distribution seems to be particularly attractive for
future studies.
Interestingly, our results on Akt3 are similar to the ones on
brains of Akt3 knock-out mice [15,16]. In both cases, a reduction
in growth was associated with a marked decrease in S6 phos-
phorylation, but minor changes or no alteration in S6K1 were
reported. However, we observed a S6 phosphorylation recovery
on 9 DIV for Akt3 disrupted cortical neurons, although this
difference could be explained by temporal changes during culture
(the fact that total S6 undergoes a marked increase at these days in
culture is a point worthy to mention). In agreement with our
results, Akt12/2 mouse brains show no statistically significant
reduction in cell size or S6 phosphorylation [15]. Thus, Akt3
seems to be a master regulator of differentiated neuron growth.
Indeed, some publications suggest that Akt3 may be responsible
for rare cases of human microcephalia associated with corpus
callosum abnormalities caused by cytogenetic deletion of 1q44-
qter, which contains the human Akt3 gene [84,85,86]. This
phenotype strongly resembles the one of Akt32/2 mice, so the
study of Akt3 may help in the understanding of the molecular basis
of human pathologies.
Another complementary research line that linked class I
PI3K.Akt pathway to neuron growth is based on studies on
PTEN depletion. PTEN is the main physiological class I
PI3K.Akt pathway inhibitor, a lipid phosphatase that dephos-
phorylates phosphatidylinositol (3,4,5)-triphosphate (PIP3) to
phosphatidylinositol (4,5)-biphosphate (PIP2) and therefore deac-
tivates class I PI3K induced signalling [87]. In fact, brains of
conditional PTEN knock-out mice show the inverse phenotype of
Akt32/2 mice: neuronal hypertrophy kinked to a marked
increase in S6 phosphorylation and reversed by mTORC1
inhibition [34,88,89]. In humans, PTEN inactivating mutations
have been linked to neuronal diseases, including autism [90] or
Lhermitte-Duclos disease, which is in fact characterized by
hypertrophy of the stratum granulosum of the cerebellum due to a
deregulation of postnatal neuron growth [91]. Our results may
help to explain the molecular mechanisms controlling these
syndromes. On the basis of our results and previous work from
other laboratories, we believe that a study combining Akt3
depletion and PTEN inactivation in neuronal growth and cell
growth related pathways would be very informative and could
shed light on the roles these biochemical pathways play in
neurological diseases.
In summary, our data show that the three Akt isoforms show
redundancy of function but suggest a fine regulation of some
aspects of apoptotic regulation and axon growth. Future work will
help to elucidate the complex molecular mechanisms underlying
these processes and the fascinating relation between Akt paralogs
and the cell growth machinery. Our results may also help to
develop a comprehensive model of the molecular basis of
syndromes related to neuron growth.
Materials and Methods
Cells and cell culture
HEK293T (ATCCH Number: CRL-11268) human embryonic
kidney cells were used to package viral particles generated to infect
neurons. This cell line was maintained in Dulbecco’s modified
eagle medium (DMEM) with 10% fetal bovine serum (FBS),
2 mM glutamine and Penicilin/Streptomycin at 37uC and 5%
CO2.
Hippocampal and cortical neurons were obtained from E18
mouse embryos as previously described [43]. Briefly, after isolating
the embryonic hippocampi or cortex from 8–10 mice in Ca2+-and
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Mg2+-free Hanks Buffer Salt Solution (HBSS 16, GIBCO),
hippocampi were incubated in 0.25% trypsin (GIBCO) for
15 min at 37uC. 1 mg/ml DNAse-I (Roche) was also added in
the case of cortex. Trypsin was eliminated by washing three times
with Hank’s buffered salt solution (HBSS) and tissue was
homogenized using two Pasteur pipettes. Cells were counted and
plated in 1 mg/ml poly-lysine (Sigma) coated dishes containing
plating medium (MEM, 20% Glucose, 10% horse serum–GIBCO-
and antibiotics), and incubated for 3 h. Afterwards, the medium was
changed to neurobasal medium supplemented with B27 (GIBCO).
Cell density was 46104 cells/cm2 for Western blot analysis, and 104
cells/cm2 for immunocytochemistry. Neurons were maintained
under these conditions for the time indicated in each experiment.
Plasmids
ShRNA containing pLKO1.puro plasmids were from MIS-
SIONH (Sigma): TRCN0000022937 for Akt1, TRCN0000055260
for Akt2 and TRCN0000054726 for Akt3. The scrambled control
shRNA was from Addgene (#1864, [92]); pEGFP.N1 was from
Clontech. pM2D.G and pCMVDR8.2 plasmids were used for
lentiviral packaging [93].
Lentiviral vector packaging and infection
Lentiviral vectors were packaged in HEK-293T cells as
previously described [93]: pM2D.G, pCMVDR8.2 and shRNA
containing pLKO1.puro were transfected into HEK-293T in a
ratio 1:1:3. 48 hours after transfection medium containing the
viral particles was filtered using 0.45 mm low binding protein
filters. Cortical neuron cultures were infected with this medium for
six hours at 37uC .
Transfection
Hippocampal neurons were nucleofected with the Amaxa Basic
Nucleofector Kit for Primary Mammalian Neural cells (Lonza,
Basel, Switzerland); a total of 3 mg of plasmid plus 1 mg pEGFP.N1
were introduced into 36106 cells. Transient transfection of
N2a cells was driven by LipofectAMINE 2000 (Invitrogen) in
OPTIMEM medium (GIBCO) at a ratio of 1 mg DNA per 3 ml of
LipofectAMINE 2000 for 56105 cells.
Western Blot analysis
Cell extracts were prepared in lysis buffer containing 200 mM
HEPES at pH 7.4, 100 mM NaCl, 100 mM NaF, 1 mM
Na3VO4, 5 mM EDTA, 1% Triton-X-100 and a protease
inhibitor cocktail (COMPLETETM, Roche, Basel, Switzerland).
Cells were left for 20 minutes on ice in lysis buffer. After this time
we obtained the cell extract and we added Laemmli sample buffer
[94]. Samples were boiled for 10 min and resolved by Tris/
Glycine SDS-Polyacrylamide gel electrophoresis. Proteins were
transferred for 145 minutes at 0.35A to a nitrocellulose membrane
(Whatman, Dassel, Germany) in the presence of 20% methanol.
Non-specific signals were blocked by incubating the membrane in
phosphate buffered saline (PBS)-Tween 20 (PBT) containing 7.5%
non-fat milk for 10 minutes. Primary and secondary antibodies
were incubated in PBT. Western blots were analysed with GS-710
densitometer (Biorad, Hercules, California).
Subcellular fractionation
Cells were harvested in 320 mM sucrose, 20 mM HEPES
pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, and 1 mM DTT, and maintained on ice for 20 minutes.
Then, samples were sequentially centrifuged for 5 minutes at
7206g to obtain the nuclear fraction; after that for 20 minutes at
100006g to obtain the mitochondrial fraction(pellet), and finally
for 60 minutes at 1000006g to separate the cytosolic fraction
(supernatant) and membrane fraction (pellet). Each fraction was
analysed by western-blot as indicated.
Immunocytochemistry
Neurons were fixed for 20 minutes at RT with 4% parafor-
maldehyde and washed for 10 minutes in PBS. Fixed cells were
incubated with 50 mM NH4Cl, blocked and permeabilized for
1 hour with 0.22% gelatin from cold water fish (Sigma) and 0.1%
Triton-X-100 in PBS. Cells were incubated with the primary
antibodies for 1 h at RT and after 3 washes with blocking solution,
the secondary antibodies were added (Invitrogen); nuclei were
stained with DAPI 1 mg/ml (Calbiochem). Coverslips were
mounted with Fluoromount G (Southern Biotechnology Associ-
ates, Inc, Birmingham, Alabama). Photographs were taken with
Zeiss Axiovert200 microscope.
Antibodies and chemicals
Primary antibodies for Akt, Akt pT308, Akt pS473, Akt2, Akt3,
GSK3a/b pS21/9, p70 S6K1, pT389, S6, S6 pS235/236, S6
pS240/244, 4EBP1 pT37/46, 4EBP1, 4EBP2, GAPDH, ERK
pT202/Y204, p38 MAPK pT180/Y182, p38 MAPK, SAPK/
JNK, pT183/Y185, SAPK/JNK, TSC2 pT1462, TSC2, PRAS40
pT246, and PRAS40 were from Cell Signaling (Danvers,
Massachussetts); antibodies against Akt1 (PKBa) and PDK1 were
from BD Transduction Laboratories, and Lamin B1 and p70
S6K1 were from Santa Cruz Biotech (Santa Cruz, California);
primary antibody for Tau-1 was from Chemicon (city, country),
against GFP and GSK3a/b were from Invitrogen, and the one for
Sin1 was a generous gift of Dr. Alessi’s lab [95]. Secondary
antibodies for western-blot (horseradish peroxidase conjugated)
were from Santa Cruz Biotech and secondary antibodies for
immunocytochemistry (Alexa-conjugated) were from Invitrogen.
Akt inhibitor VIII was from Calbiochem and used at 5 mm, and
identical amount of DMSO was used as control.
Viability assay
Cells were treated with 1 mM calcein AM (Invitrogen) and
2 mM propidium iodide for 2 minutes. Photographs were taken
with a Leica DM IRE 2 fluorescence microscope.
Data analysis
All experiments were repeated at least 3 times. Axon and were
measured using the NeuronJ 1.4.0 application [96] of ImageJ
1.42j; at least 50 neurons were counted for each condition. The
statistical analysis was performed using SigmaPlot 11.0 (Systal
Software, Inc).
Supporting Information
Figure S1 Evolution of Akt regulators in neuron cul-
tures. The two main known Akt kinases, PDK1 and mTORC2,
were analysed in cortical (left) and hippocampal (right) neuron
cultures at DIV 1, 2, 4, 6, 8, and 10. Cell extracts were obtained as
described in Methods, and Western blots analysed with specific
antibodies against PDK1 and mSin1, a well known mTORC2
component. b-actin was used as load control for cortical neurons
and GAPDH for hippocampal neurons. Protein expression was
quantified and normalised with respect the control protein as
previously indicated. The data from DIV 1 was always considered
as 1 relative units and the values are represented in logarithmic
scale. The graphs represent three independent experiments (each
point represents mean6 SEM). Samples were compared to 1 DIV
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using Student’s t test; *: p,0.05; **: p,0.01; ***: p,0.001. Note
that mSin1 antibody recognized two isoforms, only the large one
(80 kDa, marked with an arrow) is part of the mTORC2 complex.
The changes observed in Akt phosphorylation did not correlate
with changes in these proteins.
(TIF)
Figure S2 Evolution of Akt substrates implicated in
mTORC1 regulation in neuron cultures. Cortical (left) and
hippocampal (right) neuron cultures were analysed at 1, 2, 4, 6, 8
and 10 DIV. Cell extracts were obtained as described in Methods,
and the Western blots analysed with specific antibodies against the
indicated proteins. b-actin was used as load control for cortical
neurons and GAPDH for hippocampal neurons. Protein expres-
sion was quantified and normalised with respect the control
protein as indicated. The data from DIV 1 was always considered
as 1 relative units and the values are represented in logarithmic
scale. The graphs represent three independent experiments (each
point represents mean6 SEM). Samples were compared to 1 DIV
using Student’s t test; *: p,0.05; **: p,0,01; ***: p,0.001. Slight
variations were observed for Akt phosphorylated residues of TSC2
and PRAS40 in both cortical and hippocampal neurons. Note that
TSC2 suffered a marked decrease in hippocampal neurons along
the development.
(TIF)
Figure S3 Regulation of Akt substrates implicated in
mTORC1 by Akt isoforms. Cortical neurons were infected
with lentiviral vectors containing shRNA at two times (1 DIV and
6 DIV) for six hours; proteins were extracted 72 h after infection
(at 4 DIV and 9 DIV respectively) and interference was confirmed
at the protein level using specific antibodies (see Figure 6A). The
cell extract was examined using antibodies against the subtrates of
Akt implicated in mTORC1 regulation: TSC2, TSC2 pT1462,
PRAS40 and PRAS40 pT246. b-actin was used as load control.
No statistically significant difference was observed.
(TIF)
Figure S4 Regulation of MAPKs by Akt isoforms. Cortical
neurons were infected with lentiviral vectors containing shRNA at
two times (1 DIV and 6 DIV) for six hours; proteins were extracted
72 h after the infection (at 4 DIV and 9 DIV respectively) and
interference was confirmed at the protein level using specific
antibodies (see Figure 6A). The cell extract was examined using
antibodies against the reporters of the main MAPK pathways
activation: ERK1/2, ERK1/2 pT202/Y204, JNK, JNK pT183/
Y185, p38 and p38 pT180/Y182. No statistically significant
difference was observed.
(TIF)
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